[1]苏秋霞.他克莫司软膏联合胸腺肽治疗慢性乙型肝炎合并口腔扁平苔藓的疗效及对患者免疫功能的影响[J].内科,2018,13(04):599-602.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.18]
 SU Qiuxia.The efficacy of tacrolimus ointment combined with thymic peptide on the treatment of patients with chronic hepatitis B complicated with lichen planus of mouth and its influence on immunologic function[J].Internal Medicine of China,2018,13(04):599-602.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2018.04.18]
点击复制

他克莫司软膏联合胸腺肽治疗慢性乙型肝炎合并口腔扁平苔藓的疗效及对患者免疫功能的影响()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
13卷
期数:
2018年04
页码:
599-602
栏目:
论著
出版日期:
2018-08-13

文章信息/Info

Title:
The efficacy of tacrolimus ointment combined with thymic peptide on the treatment of patients with chronic hepatitis B complicated with lichen planus of mouth and its influence on immunologic function
文章编号:
1673-7768(2018)04-0599-04
作者:
苏秋霞
甘肃省平凉市庄浪县人民医院,庄浪县744600
Author(s):
SU Qiuxia
Zhuanglang County People′s Hospital of Gansu,Zhuanglang 744600,China
关键词:
慢性乙型肝炎口腔扁平苔藓治疗他克莫司软膏胸腺肽
Keywords:
Chronic hepatitis BLichen planus of mouthTreatmentTacrolimus ointmentThymic peptide
分类号:
R 575.1
DOI:
DOI:10.16121/j.cnki.cn45-1347/r.2018.04.18
文献标志码:
A
摘要:
目的分析他克莫司软膏联合胸腺肽治疗慢性乙型肝炎合并口腔扁平苔藓的疗效及对患者免疫功能的影响。方法选取2015年9月至2017年1月我院收治的慢性乙型肝炎合并口腔扁平苔藓患者118例作为研究对象,按入院顺序分为两组。对照组给予曲安奈德口腔软膏联合胸腺肽治疗,观察组患者给予他克莫司软膏联合胸腺肽治疗,比较两组患者的临床疗效;检测比较两组患者的T淋巴细胞亚群水平、ALT复常率、HBeAg和乙肝病毒DNA(HBV DNA)转阴率及不良反应发生情况。结果治疗4个月后,观察组患者的治疗总有效率(86.4%)显著高于对照组(67.8%),临床疗效显著优于对照组,差异有统计学意义(P<0.05);两组患者的CD4+和CD4+/CD8+水平均有所升高、CD8+水平有所下降,观察组患者的CD4+和CD4+/CD8+水平显著高于对照组、CD8+水平显著低于对照组,差异有统计学意义(P<0.05);观察组患者的HBeAg转阴率(66.1%)显著高于对照组(42.4%),HBV DNA转阴率(76.3%)显著高于对照组(55.9%),差异有统计学意义(P<0.05)。治疗过程中,观察组患者的不良反应发生率(11.9%)显著低于对照组(28.8%),差异有统计学意义(P<0.05)。结论他克莫司软膏联合胸腺肽进治疗慢性乙型肝炎合并口腔扁平苔藓患者能取得较好的临床治疗效果,能有效提高患者的免疫功能,提高HBeAg、HBV DNA转阴率,促进患者康复。
Abstract:
ObjectiveTo analyze the tacrolimus ointment combined with thymic peptide on the treatment of patients with chronic hepatitis B complicated with lichen planus of mouth and its influence on immunologic function. MethodsA total of 118 patients with chronic hepatitis B complicated with lichen planus of mouth treated in our hospital from September 2015 to January 2017 were selected as the subjects and randomly divided into two groups according to the order of admission.Control group was given triamcinolone acetonide dental pastetreatment combined with thymic peptide,while observation group was treated with tacrolimus ointment combined with thymic peptide.The clinical efficacy,T lymphocyte subgroup,alanine transaminase (ALT) recurrence rate,hepatitis B virus surface e antigen (HBeAg),hepatitis B virus DNA (HBV DNA) negative rate and the incidence of adverse reactions were compared between two groups. ResultsAfter 4 month treatment,the total effective rate of the observation group (83.05%) was significantly higher than that of control group (67.80%),with statistical significance(P<0.05).The levels of CD4+ and CD4+/CD8+ in the two groups were higher than those before treatment,the level of CD8+ was lower than that before treatment (P<0.05),while the levels of CD4+ and CD4+/CD8+ in the observation group were significantly higher than those in the control group,the level of CD8+ was significantly lower than that in the control group,with statistical significance(P<0.05).The HBeAg negative rate of observation group (66.10%) was significantly higher than that in control group (42.37%),the negative rate of HBV DNA (76.27%) was significantly higher than that in control group (55.93%),with statistical significance(P<0.05).The incidence of adverse reactions of observation group (11.86%) was significantly lower than that of control group (28.81%),with statistical significance(P<0.05). ConclusionTacrolimus ointment combined with thymic peptide is effective in the treatment of patients with chronic hepatitis B complicated with lichen planus of mouth,which can effectively improve immune dysfunction,enhance HBeAg and HBV DNA negative rate, improve the prognosis of patients.

相似文献/References:

[1]秦玉.个性化护理在慢性乙型肝炎患者中的应用[J].内科,2015,(01):132.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.55]
 [J].Internal Medicine of China,2015,(04):132.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.01.55]
[2]李正军 王争艳 金钊 严兴耘.延长聚乙二醇干扰素α-2a疗程对慢性乙型肝炎患者疗效的影响[J].内科,2015,(04):442.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.04.03]
 LI Zheng-jun,WANG Zheng-yan,JIN Zhao,et al.Impact of extended peginterferon alfa-2a therapy on the curative effect of patients with HBeAg-positive chronic hepatitis B[J].Internal Medicine of China,2015,(04):442.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.04.03]
[3]巨煜华.阿德福韦酯联合胸腺五肽治疗HBeAg阴性的慢性乙型肝炎疗效观察[J].内科,2013,(05):476.
 [J].Internal Medicine of China,2013,(04):476.
[4]康迪 肖健 运晨霞 秦银鸽 王颖君 冷静*.慢性乙型肝炎患者外周血CD8+T细胞CD95表达的研究[J].内科,2013,(06):565.
 KANG Di,XIAO Jiang,YUN Chen-xia,et al.Study on CD95 expression of CD8+ T lymphocytes in patients with chronic hepatitis B[J].Internal Medicine of China,2013,(04):565.
[5]陈尚军,陈梦汀,欧阳成.恩替卡韦治疗慢性乙型肝炎33例疗效观察[J].内科,2011,(01):21.
 [J].Internal Medicine of China,2011,(04):21.
[6]张苏宁(综述),赵守松*(审校).慢性乙型肝炎与急性戊型肝炎重叠感染机制研究进展▲[J].内科,2011,(01):55.
 [J].Internal Medicine of China,2011,(04):55.
[7]梁勇.长疗程干扰素α-2b联合拉米夫定治疗慢性乙肝的临床观察[J].内科,2010,(04):360.
 LIANG Yong.Long-term effect of interferon alpha-2b combined with lamivudine in treatment for of chronic hepatitis B patients[J].Internal Medicine of China,2010,(04):360.

更新日期/Last Update: 2018-08-14